Select to view the solutions available in your location.
Track orders, get results, manage personal information, and more.
Order tests, track orders, get results, and more.
Learn more about our innovative products and services that help detect cancer earlier and power smarter treatment decisions.
Find out how our scientific rigor, quality standards, and development of future tests make us a leader in cancer testing and treatment guidance.
How one revolutionary test could change the health of millions.
Learn all about Exact Sciences, including our purpose, the people who drive it, our history, and the impact we’ve made.
Several Exact Sciences initiatives address disparities in cancer outcomes among U.S. Latinos.
Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts.
Thanks to your participation, our 2015 Investor & Analyst Day was a huge success. If you'd like to revisit the presentations from yesterday, please do so below.
You can also download all slides right away.
CEO Kevin Conroy and Senior Vice President of Operations Ana Hooker gave an overview of the day's agenda, shared the Exact Sciences mission and story, and provided background on Exact Sciences Laboratories. Download now »
COO Maneesh Arora delivered an update on the commercialization of Cologuard, sharing learnings from the product's launch, sales and marketing metrics, and future plans. Download now »
Chief Science Officer Graham Lidgard presented on the strength of Exact Sciences' R&D team and the flexibility of the Cologuard platform. Download now »
CEO Kevin Conroy briefly discussed potential new screening populations for Cologuard. Download now »
Mayo Clinic gastrointestinal researcher and co-founder of Cologuard Dr. David Ahlquist discussed the current pancreatic cancer landscape and the potential for developing a pancreatic cancer screening test in collaboration with Exact Sciences. Download now »
Mayo Clinic gastrointestinal researcher and co-founder of Cologuard Dr. David Ahlquist discussed the current esophageal cancer landscape and the potential for developing an esophageal cancer screening test in collaboration with Exact Sciences. Download now »
University of Texas MD Anderson Cancer Center lung cancer researcher Dr. Sam Hanash presented on his team's newly-announced collaboration with Exact Sciences and the progress MD Anderson has made so far in developing a lung cancer screening test. Download now »
CEO Kevin Conroy offered key takeaways from Investor & Analyst Day and revisited the Exact Sciences vision. Download now »